U
Upstream Bio, Inc. (UPB)
NMS – Real vaqt narxi. Valyuta: USD
8.95
-0.16 (-1.76%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
8.95
-0.16 (-1.76%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Upstream Bio, Inc., klinik bosqichdagi biotexnologiya kompaniyasi, yallig'lanish kasalliklari uchun davolash usullarini ishlab chiqadi, og'ir nafas olish kasalliklariga e'tibor qaratadi. Kompaniya verekitugni taklif etadi, u og'ir astma va burun poliplari bilan kechadigan surunkali rinosinusit hamda surunkali obstruktsiya o'pka kasalligini davolash uchun 2-bosqich sinovlarida va surunkali obstruktsiya o'pka kasalligini davolash uchun 1-bosqich klinik sinovida. Kompaniya 2021 yilda tashkil etilgan va Uoltem, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Adam Houghton M.B.A., Ph.D. | Chief Business Officer |
| Dr. E. Rand Sutherland M.D., M.P.H. | CEO & Director |
| Meggan Buckwell | Director of Corporate Communications & Investor Relations |
| Mr. Aaron Deykin M.D. | Chief Medical Officer and Head of Research & Development |
| Mr. Michael Paul Gray CPA, MBA | CFO & COO |
| Ms. Allison C. Ambrose J.D. | Senior VP, General Counsel & Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-16 | DEFA14A | defa14a_2026_proxy.htm |
| 2026-03-26 | 8-K | d110609d8k.htm |
| 2026-02-11 | 8-K | d103888d8k.htm |
| 2025-11-05 | S-3ASR | d44481ds3asr.htm |
| 2025-09-02 | 8-K | upb-20250902.htm |
| 2025-08-06 | 8-K | upb-20250806.htm |
| 2025-08-06 | 10-Q | upb-20250630.htm |
| 2025-06-12 | 8-K | upb-20250610.htm |
| 2025-05-06 | 8-K | upb-20250506.htm |
| 2025-04-17 | DEFA14A | defa14a_2025_proxy.htm |
| Ms. Fang Xie Ph.D. | VP & Head of Biometrics |
| Ms. Lisa Fiering | Senior Vice President of People & Culture |
| Ms. Mersedeh Miraliakbari Pharm.D. | Senior Vice President of Regulatory Affairs & Quality |
| Ms. Stacy Price M.S., P.M.P. | Chief Technology Officer |